AIM: The aim of this paper is to systematically review the literature on the use of primary and community care services by long-term survivors of adult cancers. METHODS: We conducted a systematic search of eight databases and considered papers looking at primary care aspects of surviving cancer at least 3 years past diagnosis. RESULTS: Ten eligible papers in four categories: consultation rates in primary care, cancer screening, use of preventative services and chronic disease management. There was no conclusive evidence that cancer survivors have increased rates of consultation in primary care. The studies reported that cancer screening is well managed in survivors. Preventative and chronic care is worse in long-term colorectal cancer survivors compared with long-term breast cancer survivors and controls. CONCLUSION: We found little research, especially outside the United States, relating to the care of long-term cancer survivors in primary care. Future work should examine screening for treatment-specific sequelae and the quality of care for co-morbid disease.
AIM: The aim of this paper is to systematically review the literature on the use of primary and community care services by long-term survivors of adult cancers. METHODS: We conducted a systematic search of eight databases and considered papers looking at primary care aspects of surviving cancer at least 3 years past diagnosis. RESULTS: Ten eligible papers in four categories: consultation rates in primary care, cancer screening, use of preventative services and chronic disease management. There was no conclusive evidence that cancer survivors have increased rates of consultation in primary care. The studies reported that cancer screening is well managed in survivors. Preventative and chronic care is worse in long-term colorectal cancer survivors compared with long-term breast cancer survivors and controls. CONCLUSION: We found little research, especially outside the United States, relating to the care of long-term cancer survivors in primary care. Future work should examine screening for treatment-specific sequelae and the quality of care for co-morbid disease.
Authors: Jessica R Schumacher; Whitney P Witt; Mari Palta; Noelle K Loconte; Susan M Heidrich; Amy Trentham-Dietz; Nancy Pandhi; Maureen A Smith Journal: J Am Board Fam Med Date: 2012 Jul-Aug Impact factor: 2.657
Authors: Hiroko Kunitake; Ping Zheng; Greg Yothers; Stephanie R Land; Louis Fehrenbacher; Jeffrey K Giguere; D Lawrence Wickerham; Lawrence Wickerham; Patricia A Ganz; Clifford Y Ko Journal: J Clin Oncol Date: 2010-11-15 Impact factor: 44.544
Authors: Antonella Surbone; Lea Baider; Tammy S Weitzman; Mary Jacqueline Brames; Cynthia N Rittenberg; Judith Johnson Journal: Support Care Cancer Date: 2009-07-17 Impact factor: 3.603
Authors: Aimee Kendall Roundtree; Sharon H Giordano; Andrea Price; Maria E Suarez-Almazor Journal: Support Care Cancer Date: 2010-12-09 Impact factor: 3.603
Authors: Carrie N Klabunde; Paul K J Han; Craig C Earle; Tenbroeck Smith; John Z Ayanian; Richard Lee; Anita Ambs; Julia H Rowland; Arnold L Potosky Journal: Fam Med Date: 2013 Jul-Aug Impact factor: 1.756